These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2469344)

  • 21. Antigen-presenting activity of non-Langerhans epidermal cells in contact hypersensitivity reactions.
    Baadsgaard O; Lisby S; Avnstorp C; Clemmensen O; Lange-Vejlsgaard G
    Scand J Immunol; 1990 Sep; 32(3):217-24. PubMed ID: 1698306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
    Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratinocytes in lesional skin of atopic eczema bear HLA-DR, CD1a and IgE molecules.
    Bieber T; Dannenberg B; Ring J; Braun-Falco O
    Clin Exp Dermatol; 1989 Jan; 14(1):35-9. PubMed ID: 2478318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocompetent cells in human nasal polyps and normal mucosa.
    Linder A; Karlsson-Parra A; Hirvelä C; Jonsson L; Köling A; Sjöberg O
    Rhinology; 1993 Sep; 31(3):125-9. PubMed ID: 8256081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Langerhans cells and T-lymphocytes in the normal human ectocervix defined by monoclonal antibodies and electron microscopy.
    Roig de Vargas-Linares C
    Microsc Electron Biol Celular; 1989 Jun; 13(1):53-63. PubMed ID: 2636973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-epithelial lymphocytes and non-lymphoid cells in the human nasal mucosa.
    Hameleers DM; Stoop AE; van der Ven I; Biewenga J; van der Baan S; Sminia T
    Int Arch Allergy Appl Immunol; 1989; 88(3):317-22. PubMed ID: 2470681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric analysis and sorting of HLA-DR+CD1+ Langerhans cells.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Jul; 121(1):11-8. PubMed ID: 2474321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma.
    Ediger D; Sin BA; Heper A; Anadolu Y; Misirligil Z
    Clin Exp Allergy; 2005 Mar; 35(3):319-26. PubMed ID: 15784110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells.
    Davis AL; McKenzie JL; Hart DN
    Immunology; 1988 Dec; 65(4):573-81. PubMed ID: 3065220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The regulation of Langerhans cell T6, DR and DQ antigen expression: an hypothesis.
    Walsh LJ; Seymour GJ; Powell RN
    J Oral Pathol; 1988 Jan; 17(1):43-6. PubMed ID: 3131509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal human skin lymphocytic and Langerhans' cell responses to intradermal interferon alpha-2 beta injections.
    Tong Y; Tucker SB
    Am J Med Sci; 1993 Jul; 306(1):23-7. PubMed ID: 7687094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps.
    Liu CM; Shun CT; Hsu MM
    Ann Allergy; 1994 Jan; 72(1):19-24. PubMed ID: 8291744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
    Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
    Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
    Claudy AL; Rouchouse B
    Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal DR+T6- dendritic cells in inflammatory skin diseases.
    Baker BS; Lambert S; Powles AV; Valdimarsson H; Fry L
    Acta Derm Venereol; 1988; 68(3):209-17. PubMed ID: 2455413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combined regimen of etretinate and UVB modulate T6+ and HLA-DR+ epidermal cells.
    Kim YH; Kim CW; Houh W
    J Korean Med Sci; 1987 Jun; 2(2):89-96. PubMed ID: 3271057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.